Oncology Institute Inc.

NASDAQ: TOI · Real-Time Price · USD
3.67
0.00 (0.00%)
At close: Aug 15, 2025, 3:07 PM

Oncology Institute Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-17.01M -19.59M -13.18M -16.11M -15.48M -19.89M -18.75M -17.42M -16.9M -30M -9.5M -2.67M -5.45M 19.29M -10.16M -2.98M 3.21M -996K
Depreciation & Amortization
1.8M 1.78M 1.71M 1.57M 1.52M 1.49M 1.58M 1.7M 1.33M 1.27M 1.19M 1.13M 1.1M 987K 919K 849.62K 794.38K 777K
Stock-Based Compensation
752K 1.46M 1.29M 2.39M 3.39M 4.09M 4.08M 4.66M 4.11M 4.96M 6.07M 6.55M 6.51M 8.55M 24.38M 59.06K 50.94K 42K
Other Working Capital
2.09M 1.33M 5.75M 3.16M -2.94M 5M 2.82M 731K 2.97M 4.56M 828K 2.01M 3.91M 962K -10.84M 1.25M -4.24M 468K
Other Non-Cash Items
7.45M 8.23M 1.64M 1.51M -1.68M 1.16M 2.88M 3.78M 1M 13.12M -6.14M -17.86M -12.76M -37.99M -28.1M 72.55K -5.89M 18K
Deferred Income Tax
-32K n/a n/a n/a n/a n/a -126K 80K -4K -26K -446K 52K -49K 180K 2.3M -3.76M -262 221K
Change in Working Capital
-3.17M 3.13M 12.73M 11.46M -3.41M -2.73M 6.45M -1.11M 1.8M -4.78M -5.17M -7.6M 271K -7.99M -12.68M 3.08M -5.29M 402K
Operating Cash Flow
-10.2M -4.99M 4.19M 819K -15.66M -15.88M -3.89M -8.31M -8.66M -15.45M -14M -20.4M -10.38M -16.98M -23.34M -2.68M -7.13M 464K
Capital Expenditures
-1.21M -328K -1.75M 402K -1.83M -610K -861K -930K -937K -1.84M -2M -1.19M -1.34M -1M -871K -949.66K -607.34K -619K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -156K -8.64M -4.3M -20.24M -470K 813K -8.92M n/a -8.28M 457.00 -457 -827K
Purchase of Investments
n/a n/a n/a n/a n/a n/a 88K 64K 12K -9.76M -30.11M -87.4M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a 10M 20M 20M 12.56M 8.57M 30.13M 30M 30.58M 86.59M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a 126K n/a n/a n/a n/a n/a 8.64M 30.14M 20.24M -30.58M -86.59M n/a n/a n/a n/a 300K n/a
Investing Cash Flow
-1.21M -202K -1.75M 10.4M 18.18M 19.39M 11.63M 7.71M 24.9M 18.4M -32.57M -87.78M -10.26M -1M -9.15M -949.21K -607.79K -1.45M
Debt Repayment
19.87M -20.01M -10K -11K -9K -9K -10K -10K -63K -18K -19K 109.99M -13K -13K -5.54M -8K -4.51M 2.4M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a -125K n/a n/a n/a -9M -9M n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-20.11M -89K -81K -232K -2.14M -1M -1.88M -621K -2.54M -1.69M -412K -4.59M -2.01M -1.64M 121.67M n/a n/a n/a
Financial Cash Flow
1.96M -4.74M -164K -243K -2.15M -938K -1.78M -756K -2.6M -1.71M -847K 105.39M -10.69M -1.66M 136.13M -8.72K -4.51M 22.4M
Net Cash Flow
-9.45M -9.93M 2.27M 10.98M 369K 2.57M 5.95M -1.36M 13.64M 1.24M -47.41M -2.78M -31.33M -19.64M 103.64M -3.64M -12.24M 21.41M
Free Cash Flow
-11.41M -5.32M 2.43M 1.22M -17.49M -16.49M -4.75M -9.24M -9.6M -17.29M -15.99M -21.59M -11.72M -17.98M -24.21M -3.63M -7.74M -155K